Cell-specific cargo delivery using synthetic bacterial spores

Area of Science:

• Biotechnology
• Nanomedicine
• Oncology

Background:

• Targeted cancer therapy improves efficacy and reduces toxicity.
• HER2 overexpression in ovarian cancer correlates with poor prognosis.
• Bacterial spore-like shells (SSHELs) offer a novel drug delivery platform.

Purpose of the Study:

• To develop HER2-targeted SSHELs for ovarian cancer treatment.
• To evaluate the efficacy and toxicity of doxorubicin-loaded SSHELs.
• To investigate the cellular uptake and drug release mechanism of SSHELs.

Main Methods:

• SSHELs were modified with an anti-HER2 affibody.
• Doxorubicin was loaded into the modified SSHELs.
• Efficacy and toxicity were assessed in a mouse xenograft model.

Main Results:

• SSHELs preferentially accumulated in tumor masses.
• Drug-loaded SSHELs reduced tumor growth and increased survival.
• Lower toxicity was observed compared to free drug and liposomal doxorubicin.
• SSHELs were internalized by target cells and released doxorubicin in an acidic, pH-dependent manner.

Conclusions:

• HER2-targeted SSHELs represent a promising strategy for ovarian cancer drug delivery.
• This platform demonstrates enhanced therapeutic efficacy and reduced systemic toxicity.
• SSHELs facilitate targeted internalization and pH-dependent drug release within cancer cells.